A User-Driven Framework for Dose Selection in Pregnancy: Proof of Concept for Sertraline
Author Information
Author(s): Koldeweij Charlotte, Dibbets Caroline, Franklin Bryony D., Scheepers Hubertina C. J., de Wildt Saskia N.
Primary Institution: Radboud University Medical Center
Hypothesis
Can an effective method for establishing evidence-based, acceptable and clinically feasible antenatal doses be developed through a user-driven approach?
Conclusion
The study developed a user-driven framework for selecting antenatal doses of sertraline, which has been endorsed for clinical use.
Supporting Evidence
- Pregnancy-induced changes in physiology may alter drug pharmacokinetics.
- Most drugs are used off-label in pregnancy due to lack of evidence-based dosing.
- The framework was piloted for sertraline, a commonly prescribed antidepressant in pregnancy.
- Maternal changes during pregnancy can affect drug safety and efficacy.
- Stakeholder analysis revealed a high willingness to use model-informed antenatal doses.
Takeaway
This study created a guide to help doctors choose the right dose of sertraline for pregnant women, making sure it's safe for both mom and baby.
Methodology
The framework was developed through expert evaluation and piloted with a multidisciplinary committee, including healthcare practitioners and pregnant women.
Potential Biases
The framework may differ in accessibility for readers with varying clinical and pharmacological knowledge.
Limitations
The framework requires assumptions when data is lacking and may be time-consuming to complete.
Participant Demographics
Participants included healthcare practitioners and pregnant women, with 31% having a medical background.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website